CYP1B1 and triple-negative breast carcinoma: Therefore, the presence of homozygous variant genotype (GG) and variant allele (G) of CYP1B1 4326C>G polymorphism of CYP1B1 was associated with lower response rates, shorter progression-free survival, and an overall decrease in patient survival among patients with triple-negative breast cancer [128].